ASweetLife Team, Author at ASweetLife

Type 1 Diabetic Potential to Create Own Insulin

Researchers from the Peninsula Medical School, working in collaboration with colleagues from Glasgow Royal Infirmary and the University of Brighton, have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate...

Type 2 Diabetes Increases Cancer Risk in Woman but Protects Men

Type 2 diabetes appears to reduce the risk of prostate cancer in men, but appears to increase the risk of some cancers in women, researchers in Israel said. Diabetes UK reports on a study led by Dr. Gabriel Chodick and Dr. Varda Shalev of Tel Aviv University's Sackler Faculty of Medicine. The study examined 16,721 people with diabetes and determined the relative

Oral Insulin AFREZZA Successful at Controlling Blood Sugar Levels in Type 1 Diabetes Patients

MannKind announced that results of a new 16-week trial show that the investigational ultra rapid acting mealtime insulin, AFREZZA (insulin human [rDNA origin]) Inhalation Powder, combined with basal insulin, is clearly non-inferior to standard therapy insulin lispro, a rapid acting insulin (also combined with basal insulin), in reducing HbA1c levels in subjects with inadequately controlled type 1 diabetes...

Children with Diabetes in California Schools: ADA Issues Statement

The American Diabetes Association (ADA) issued a statement expressing extreme disappointment in the California Court of Appeal ruling in the case of American Nurses Association et al. v. O’Connell, which prevents non-medical school personnel from volunteering to administer insulin to California schoolchildren who are not yet able to self-manage their disease...

Coffee Reduces Risk of Type 2 Diabetes

New evidence shows that drinking coffee may help prevent diabetes and lower blood sugar, according to a EurekAlert report. In a study, published in Journal of Agricultural and Food Chemistry, scientists fed either water or coffee to a group of laboratory mice commonly used to study diabetes. Coffee consumption prevented the development of high-blood sugar and also improved insulin sensitivity in the mice, thereby reducing the risk of diabetes...

Medtronic to Release New iPro 2 CGM Monitor

Medtronic, Inc. announced the launch of iPro 2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications. ..

Type 2 Diabetes May Be Prevented With a Combination of Avandia and Metformin

According to a new report published in the Lancet, taking a low dose of GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) combined with metformin was highly effective in prevention of type 2 diabetes in patients with impaired glucose tolerance, with little effect on the clinically relevant adverse events of these two drugs. The study included 207 patients with impaired glucose...

Novo Nordisk to Launch Victoza in Japan

Novo Nordisk announced that it has received approval for the price of Victoza, a once-daily human GLP-1 analogue for the treatment of type 2 diabetes, from Japan’s Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare. The price approval allows Novo Nordisk to commercially launch in Japan shortly after Victoza is officially posted on Japan’s National Health Insurance price list on June 11th...

GlaxoSmithKline Settles More Avandia Lawsuits

GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine. According to a Reuters report, a spokeswoman for Glaxo said that consolidated cases which had been due to come to court...

Novo Nordisk to Stop Insulin Sales in Greece

Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices...